{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:27:34Z","timestamp":1780471654252,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s11926-008-0027-4","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T22:01:01Z","timestamp":1209938461000},"page":"156-163","source":"Crossref","is-referenced-by-count":40,"title":["Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology"],"prefix":"10.1007","volume":"10","author":[{"given":"Reema H.","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Gilliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,4]]},"reference":[{"key":"27_CR1","doi-asserted-by":"crossref","unstructured":"Cassidy JT, Petty RE, eds: Chronic arthritis in children. In Textbook of Pediatric Rheumatology. Philadelphia: Elsevier Saunders; 2005:206\u2013260.","DOI":"10.1016\/B978-1-4160-0246-8.50015-2"},{"key":"27_CR2","first-page":"1991","volume":"25","author":"R.E. Petty","year":"1998","unstructured":"Petty RE, Southwood TR, Baum J, et al.: Revision of the proposed classification criteria for juvenile idiopathic arthritis. J Rheumatol 1998, 25:1991\u20131994.","journal-title":"J Rheumatol"},{"issue":"5Suppl31","key":"27_CR3","first-page":"S89","volume":"21","author":"A. Ravelli","year":"2003","unstructured":"Ravelli A, Martini A: Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol 2003, 21(5 Suppl 31):S89\u2013S93.","journal-title":"Clin Exp Rheumatol"},{"key":"27_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E. Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U, et al.: Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 2006, 65:453\u2013458.","journal-title":"Ann Rheum Dis"},{"key":"27_CR5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10067-006-0343-x","volume":"26","author":"A. Ates","year":"2007","unstructured":"Ates A, Kinikli G, Turgay M, et al.: Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study. Clin Rheumatol 2007, 26:538\u2013545.","journal-title":"Clin Rheumatol"},{"key":"27_CR6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/S0041-87812002000500004","volume":"57","author":"R.A. Ferreira","year":"2002","unstructured":"Ferreira RA, Ferriani VP, Sopelete MC, et al.: Immunoglobulin E-rheumatoid factor in juvenile rheumatoid arthritis. Rev Hosp Clin Fac Med Sao Paulo 2002, 57:209\u2013216.","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"27_CR7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0009-9120(93)90032-2","volume":"26","author":"T.L. Moore","year":"1993","unstructured":"Moore TL, Dorner RW: Rheumatoid factors. Clin Biochem 1993, 26:75\u201384.","journal-title":"Clin Biochem"},{"key":"27_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.1780330207","volume":"33","author":"S.M. Walker","year":"1990","unstructured":"Walker SM, McCurdy DK, Shaham B, et al.: High prevalence of IgA rheumatoid factor in severe polyarticular-onset juvenile rheumatoid arthritis, but not in systemic-onset or pauciarticular-onset disease. Arthritis Rheum 1990, 33:199\u2013204.","journal-title":"Arthritis Rheum"},{"key":"27_CR9","first-page":"936","volume":"17","author":"S.M. Walker","year":"1990","unstructured":"Walker SM, Shaham B, McCurdy DK, et al.: Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA. J Rheumatol 1990, 17:936\u2013940.","journal-title":"J Rheumatol"},{"key":"27_CR10","first-page":"513","volume":"8","author":"F.T. Saulsbury","year":"1990","unstructured":"Saulsbury FT: Prevalence of IgM, IgA and IgG rheumatoid factors in juvenile rheumatoid arthritis. Clin Exp Rheumatol 1990, 8:513\u2013517.","journal-title":"Clin Exp Rheumatol"},{"key":"27_CR11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1542\/peds.90.6.945","volume":"90","author":"J.N. Jarvis","year":"1992","unstructured":"Jarvis JN, Pousak T, Krenz M: Detection of IgM rheumatoid factors by enzyme-linked immunosorbent assay in children with juvenile rheumatoid arthritis: correlation with articular disease and laboratory abnormalities. Pediatrics 1992, 90:945\u2013949.","journal-title":"Pediatrics"},{"key":"27_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00579698","volume":"14","author":"A. Aggarwal","year":"1994","unstructured":"Aggarwal A, Dabadghao S, Naik S, Misra R: Serum IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA) delineates a subset of patients with deforming joint disease in seronegative juvenile rheumatoid arthritis. Rheumatol Int 1994, 14:135\u2013138.","journal-title":"Rheumatol Int"},{"key":"27_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4615-4857-7_9","volume":"455","author":"B.B. Varbanova","year":"1999","unstructured":"Varbanova BB, Baleva M, Nikolov K, Mihailova D: Prevalence of IgM-, IgA-and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA. Adv Exp Med Biol 1999, 455:61\u201368.","journal-title":"Adv Exp Med Biol"},{"key":"27_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002960050099","volume":"19","author":"A. Bharadwaj","year":"1999","unstructured":"Bharadwaj A, Aggarwal A, Misra R: Clinical relevance of IgA rheumatoid factor (RF) in children with juvenile rheumatoid arthritis. Rheumatol Int 1999, 19:47\u201349.","journal-title":"Rheumatol Int"},{"key":"27_CR15","first-page":"103","volume":"111","author":"A. Bhardwaj","year":"2000","unstructured":"Bhardwaj A, Aggarwal A, Agarwal V, Misra A: Role of IgM and IgA rheumatoid factors in complement activation in patients with juvenile rheumatoid arthritis. Indian J Med Res 2000, 111:103\u2013109.","journal-title":"Indian J Med Res"},{"key":"27_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00296-006-0221-5","volume":"27","author":"R.A. Ferreira","year":"2007","unstructured":"Ferreira RA, Silva CH, Silva DA, et al.: Is measurement of IgM and IgA rheumatoid factors (RF) in juvenile rheumatoid arthritis clinically useful? Rheumatol Int 2007, 27:345\u2013349.","journal-title":"Rheumatol Int"},{"key":"27_CR17","first-page":"S697","volume":"54","author":"B.E. Gilliam","year":"2006","unstructured":"Gilliam BE, Low JM, Chauhan AK, Moore TL: Biomarkers associated with joint damage in juvenile idiopathic arthritis. Arthritis Rheum 2006, 54:S697.","journal-title":"Arthritis Rheum"},{"key":"27_CR18","unstructured":"Gilliam BE, Chauhan AK, Low JM, Moore TL: Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study. Clin Exp Rheumatol 2008, In press."},{"key":"27_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002960050069","volume":"18","author":"T. J\u00f3nsson","year":"1998","unstructured":"J\u00f3nsson T, Steinsson K, J\u00f3nsson H, et al.: Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity of rheumatoid arthritis. Rheumatol Int 1998, 18:119\u2013122.","journal-title":"Rheumatol Int"},{"key":"27_CR20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.23.4.302","volume":"23","author":"R.L. Nienhuis","year":"1964","unstructured":"Nienhuis RL, Mandema E: A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor. Ann Rheum Dis 1964, 23:302\u2013305.","journal-title":"Ann Rheum Dis"},{"key":"27_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.2.6182.97","volume":"2","author":"B.J. Young","year":"1979","unstructured":"Young BJ, Mallya RK, Leslie RD, et al.: Anti-keratin antibodies in rheum atoid arthritis. Br Med J 1979, 2:97\u201399.","journal-title":"Br Med J"},{"key":"27_CR22","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI117969","volume":"95","author":"M. Sebbag","year":"1995","unstructured":"Sebbag M, Simon M, Vincent C, et al.: The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995, 95:2672\u20132679.","journal-title":"J Clin Invest"},{"key":"27_CR23","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI116713","volume":"92","author":"M. Simon","year":"1993","unstructured":"Simon M, Girbal E, Sebbag M, et al.: The cytokeratin filament-aggregating protein filaggrin is the target of the so-called \u201cantikeratin antibodies,\u201d autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993, 92:1387\u20131393.","journal-title":"J Clin Invest"},{"key":"27_CR24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.1995.tb03608.x","volume":"100","author":"M. Simon","year":"1995","unstructured":"Simon M, Vincent C, Haftek M, et al.: The rheumatoid arthritis-associated autoantibodies to filaggrin label the fibrous matrix of the cornified cells but not the profilaggrin-containing keratohyalin granules in human epidermis. Clin Exp Immunol 1995, 100:90\u201398.","journal-title":"Clin Exp Immunol"},{"key":"27_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"G.A. Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, van den Hoogen FH, et al.: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998, 101:273\u2013281.","journal-title":"J Clin Invest"},{"key":"27_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"G.A. Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, et al.: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155\u2013163.","journal-title":"Arthritis Rheum"},{"key":"27_CR27","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"E.J. Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA, et al.: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000, 43:1831\u20131835.","journal-title":"Arthritis Rheum"},{"key":"27_CR28","first-page":"689","volume":"17","author":"C.H. Jaarsveld van","year":"1999","unstructured":"van Jaarsveld CH, ter Borg EJ, Jacobs JW, et al.: The prognostic value of the antiperinuclear factor, anti-cyclic citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 1999, 17:689\u2013697.","journal-title":"Clin Exp Rheumatol"},{"key":"27_CR29","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C. Masson-Bessiere","year":"2001","unstructured":"Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, et al.: The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha-and beta-chains of fibrin. J Immunol 2001, 166:4177\u20134184.","journal-title":"J Immunol"},{"key":"27_CR30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/ar122","volume":"2","author":"H.A. Menard","year":"2000","unstructured":"Menard HA, Lapointe E, Rochdi MD, Zhou ZJ: Insights into rheumatoid arthritis derived from the Sa immune system. Arthritis Res 2000, 2:429\u2013432.","journal-title":"Arthritis Res"},{"key":"27_CR31","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#","volume":"44","author":"D. Baeten","year":"2001","unstructured":"Baeten D, Peene I, Union A, et al.: Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 2001, 44:2255\u20132262.","journal-title":"Arthritis Rheum"},{"key":"27_CR32","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/art.11229","volume":"48","author":"E.R. Vossenaar","year":"2003","unstructured":"Vossenaar ER, Nijenhuis S, Helsen MM, et al.: Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003, 48:2489\u20132500.","journal-title":"Arthritis Rheum"},{"key":"27_CR33","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1002\/art.10774","volume":"48","author":"J.A. Hill","year":"2003","unstructured":"Hill JA, Wehrli B, Jevnikar AM, et al.: Citrullinated fibrinogen induces arthritis in HLA-DRB1*0401 transgenic mice. Arthritis Rheum 2003, 48:S348.","journal-title":"Arthritis Rheum"},{"key":"27_CR34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/ard.51.3.350","volume":"51","author":"G. Nesher","year":"1992","unstructured":"Nesher G, Moore TL, Gristanti MW, et al.: Antiperinuclear factor in juvenile rheumatoid arthritis. Ann Rheum Dis 1992, 51:350\u2013352.","journal-title":"Ann Rheum Dis"},{"key":"27_CR35","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.52.11.785","volume":"52","author":"C. Gabay","year":"1993","unstructured":"Gabay C, Prieur AM, Meyer O: Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis. Ann Rheum Dis 1993, 52:785\u2013789.","journal-title":"Ann Rheum Dis"},{"key":"27_CR36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/0891693021000014970","volume":"35","author":"I. Hromadnikova","year":"2002","unstructured":"Hromadnikova I, Stechova K, Pavla V, et al.: Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Autoimmunity 2002, 35:397\u2013401.","journal-title":"Autoimmunity"},{"key":"27_CR37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard.61.7.608","volume":"61","author":"T. Avcin","year":"2002","unstructured":"Avcin T, Cimaz R, Falcini F, et al.: Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2002, 61:608\u2013611.","journal-title":"Ann Rheum Dis"},{"key":"27_CR38","first-page":"825","volume":"30","author":"M. Rossum van","year":"2003","unstructured":"van Rossum M, van Soesbergen R, de Kort S, et al.: Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol 2003, 30:825\u2013828.","journal-title":"J Rheumatol"},{"key":"27_CR39","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/ard.2003.019331","volume":"63","author":"O. Kasapcopur","year":"2004","unstructured":"Kasapcopur O, Altun S, Aslan M, et al.: Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2004, 63:1687\u20131689.","journal-title":"Ann Rheum Dis"},{"key":"27_CR40","first-page":"1829","volume":"31","author":"J.M. Low","year":"2004","unstructured":"Low JM, Chauhan AK, Kietz DA, et al.: Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J Rheumatol 2004, 31:1829\u20131833.","journal-title":"J Rheumatol"},{"key":"27_CR41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/03009740510026634","volume":"34","author":"J.S. Kwok","year":"2005","unstructured":"Kwok JS, Hui KH, Lee TL, et al.: Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand J Rheumatol 2005, 34:359\u2013366.","journal-title":"Scand J Rheumatol"},{"key":"27_CR42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/S0021-75572005000800014","volume":"81","author":"S.H. Machado","year":"2005","unstructured":"Machado SH, von M\u00fchlen CA, Brenol JC, et al.: The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. J Pediatr (Rio J) 2005, 81:491\u2013494.","journal-title":"J Pediatr (Rio J)"},{"key":"27_CR43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/s10165-006-0520-4","volume":"16","author":"J. Brunner","year":"2006","unstructured":"Brunner J, Sitzmann FC: Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Mod Rheumatol 2006, 16:372\u2013375.","journal-title":"Mod Rheumatol"},{"key":"27_CR44","first-page":"449","volume":"24","author":"J. Brunner","year":"2006","unstructured":"Brunner J, Sitzmann FC: The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2006, 24:449\u2013451.","journal-title":"Clin Exp Rheumatol"},{"key":"27_CR45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/rheumatology\/kei133","volume":"45","author":"P. Dewint","year":"2006","unstructured":"Dewint P, Hoffman IE, Rogge S, et al.: Effect of age on prevalence of anticitrullinated protein\/peptide antibodies in polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 2006, 45:204\u2013208.","journal-title":"Rheumatology (Oxford)"},{"key":"27_CR46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/ard.45.6.464","volume":"45","author":"P.J. Hall","year":"1986","unstructured":"Hall PJ, Burman SJ, Laurent MR, et al.: Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients. Ann Rheum Dis 1986, 45:464\u2013474.","journal-title":"Ann Rheum Dis"},{"key":"27_CR47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/art.20773","volume":"52","author":"E.D. Ferucci","year":"2005","unstructured":"Ferucci ED, Majka DS, Parrish LA, et al.: Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2005, 52:239\u2013246.","journal-title":"Arthritis Rheum"},{"key":"27_CR48","doi-asserted-by":"crossref","unstructured":"Syed RH, Gilliam BE, Moore TL: Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2008, In press.","DOI":"10.1136\/ard.2007.084855"},{"key":"27_CR49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-3083.2006.01859.x","volume":"65","author":"J.M. Low","year":"2007","unstructured":"Low JM, Chauhan AK, Moore TL: Abnormal kappa: lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis. Scand J Immunol 2007, 65:76\u201383.","journal-title":"Scand J Immunol"},{"key":"27_CR50","first-page":"S724","volume":"56","author":"L.M. Vieira","year":"2007","unstructured":"Vieira LM, d\u2019Orse E, Periera IA, et al.: A comparison study of second and third generation anti-cyclic citrullinated peptide antibody ELISAs. Arthritis Rheum 2007, 56:S724.","journal-title":"Arthritis Rheum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-008-0027-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-008-0027-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-008-0027-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T03:34:47Z","timestamp":1684380887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-008-0027-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s11926-008-0027-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}